Literature DB >> 24390321

Activity of hexokinase is increased by its interaction with hepatitis C virus protein NS5A.

Christophe Ramière1, Jonathan Rodriguez, Liviu S Enache, Vincent Lotteau, Patrice André, Olivier Diaz.   

Abstract

UNLABELLED: The study of cellular central carbon metabolism modulations induced by viruses is an emerging field. Human cytomegalovirus (HCMV), herpes simplex virus (HSV), Kaposi's sarcoma-associated herpesvirus (KSHV), and hepatitis C virus (HCV) have been shown recently to reprogram cell metabolism to support their replication. During HCV infection the global glucidolipidic metabolism of hepatocytes is highly impacted. It was suggested that HCV might modify glucose uptake and glycolysis to increase fatty acids synthesis, but underlying mechanisms have not been completely elucidated. We thus investigated how HCV may modulate glycolysis. We observed that in infected Huh7.5 cells and in subgenomic replicon-positive Huh9.13 cells, glucose consumption as well as lactate secretion was increased. Using protein complementation assays and coimmunoprecipitation, we identified a direct interaction between the HCV NS5A protein and cellular hexokinase 2 (HK2), the first rate-limiting enzyme of glycolysis. NS5A expression was sufficient to enhance glucose consumption and lactate secretion in Huh7.5 cells. Moreover, determination of HK activity in cell homogenates revealed that addition of exogenous NS5A protein, either the full-length protein or its D2 or D3, but not D1, domain, was sufficient to increase enzyme activity. Finally, determination of recombinant HK2 catalytic parameters (V(max) and K(m)) in the presence of NS5A identified this viral protein as an activator of the enzyme. In summary, this study describes a direct interaction between HCV NS5A protein and cellular HK2 which is accompanied by an increase in HK2 activity that might contribute to an increased glycolysis rate during HCV infection. IMPORTANCE: Substantial evidence indicates that viruses reprogram the central carbon metabolism of the cell to support their replication. Nevertheless, precise underlying mechanisms are poorly described. Metabolic pathways are structured as connected enzymatic cascades providing elemental biomolecular blocks necessary for cell life and viral replication. In this study, we observed an increase in glucose consumption and lactate secretion in HCV-infected cells, revealing higher glycolytic activity. We also identified an interaction between the HCV NS5A nonstructural protein and cellular hexokinase 2, the first rate-limiting enzyme of glycolysis. This interaction results in an enhancement of catalytic parameters of the enzyme, which might explain, at least in part, the aerobic glycolysis shift observed in HCV-infected cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390321      PMCID: PMC3957934          DOI: 10.1128/JVI.02862-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Benchmarking a luciferase complementation assay for detecting protein complexes.

Authors:  Patricia Cassonnet; Caroline Rolloy; Gregory Neveu; Pierre-Olivier Vidalain; Thibault Chantier; Johann Pellet; Louis Jones; Mandy Muller; Caroline Demeret; Guillaume Gaud; Françoise Vuillier; Vincent Lotteau; Fréderic Tangy; Michel Favre; Yves Jacob
Journal:  Nat Methods       Date:  2011-11-29       Impact factor: 28.547

2.  Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.

Authors:  Andreas Merz; Gang Long; Marie-Sophie Hiet; Britta Brügger; Petr Chlanda; Patrice Andre; Felix Wieland; Jacomine Krijnse-Locker; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2010-11-05       Impact factor: 5.157

Review 3.  Assembly of infectious hepatitis C virus particles.

Authors:  Ralf Bartenschlager; Francois Penin; Volker Lohmann; Patrice André
Journal:  Trends Microbiol       Date:  2010-12-14       Impact factor: 17.079

4.  Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Authors:  Steeve Boulant; Christophe Vanbelle; Christine Ebel; François Penin; Jean-Pierre Lavergne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

Authors:  Renate König; Yingyao Zhou; Daniel Elleder; Tracy L Diamond; Ghislain M C Bonamy; Jeffrey T Irelan; Chih-Yuan Chiang; Buu P Tu; Paul D De Jesus; Caroline E Lilley; Shannon Seidel; Amanda M Opaluch; Jeremy S Caldwell; Matthew D Weitzman; Kelli L Kuhen; Sourav Bandyopadhyay; Trey Ideker; Anthony P Orth; Loren J Miraglia; Frederic D Bushman; John A Young; Sumit K Chanda
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

6.  Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity.

Authors:  L V Ronco; A Y Karpova; M Vidal; P M Howley
Journal:  Genes Dev       Date:  1998-07-01       Impact factor: 11.361

7.  A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication.

Authors:  Dahlene N Fusco; Cynthia Brisac; Sinu P John; Yi-Wen Huang; Christopher R Chin; Tiao Xie; Hong Zhao; Nikolaus Jilg; Leiliang Zhang; Stephane Chevaliez; Daniel Wambua; Wenyu Lin; Lee Peng; Raymond T Chung; Abraham L Brass
Journal:  Gastroenterology       Date:  2013-02-24       Impact factor: 22.682

8.  Divergent effects of human cytomegalovirus and herpes simplex virus-1 on cellular metabolism.

Authors:  Livia Vastag; Emre Koyuncu; Sarah L Grady; Thomas E Shenk; Joshua D Rabinowitz
Journal:  PLoS Pathog       Date:  2011-07-14       Impact factor: 6.823

9.  Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles.

Authors:  Jieyun Jiang; Guangxiang Luo
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

10.  Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.

Authors:  Brett D Lindenbach; Philip Meuleman; Alexander Ploss; Thomas Vanwolleghem; Andrew J Syder; Jane A McKeating; Robert E Lanford; Stephen M Feinstone; Marian E Major; Geert Leroux-Roels; Charles M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-16       Impact factor: 11.205

View more
  47 in total

Review 1.  Viral activation of cellular metabolism.

Authors:  Erica L Sanchez; Michael Lagunoff
Journal:  Virology       Date:  2015-03-23       Impact factor: 3.616

2.  Dengue Virus NS1 Protein Modulates Cellular Energy Metabolism by Increasing Glyceraldehyde-3-Phosphate Dehydrogenase Activity.

Authors:  Diego Allonso; Iamara S Andrade; Jonas N Conde; Diego R Coelho; Daniele C P Rocha; Manuela L da Silva; Gustavo T Ventura; Emiliana M Silva; Ronaldo Mohana-Borges
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

Review 3.  Metabolic reprogramming: a hallmark of viral oncogenesis.

Authors:  P Lévy; B Bartosch
Journal:  Oncogene       Date:  2015-12-21       Impact factor: 9.867

4.  Differential Metabolic Reprogramming by Zika Virus Promotes Cell Death in Human versus Mosquito Cells.

Authors:  Shivani K Thaker; Travis Chapa; Gustavo Garcia; Danyang Gong; Ernst W Schmid; Vaithilingaraja Arumugaswami; Ren Sun; Heather R Christofk
Journal:  Cell Metab       Date:  2019-02-28       Impact factor: 27.287

5.  A novel 76-mer peptide mimic with the synergism of superoxide dismutase and glutathione peroxidase.

Authors:  Yawei Xu; Yan Zhou; Rui Yin; Cheng Wang; Haijiao Chu; Junling Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-03-20       Impact factor: 2.416

6.  Dengue virus induces and requires glycolysis for optimal replication.

Authors:  Krystal A Fontaine; Erica L Sanchez; Roman Camarda; Michael Lagunoff
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

Review 7.  Targeted Metabolic Reprogramming to Improve the Efficacy of Oncolytic Virus Therapy.

Authors:  Barry E Kennedy; Maryanne Sadek; Shashi A Gujar
Journal:  Mol Ther       Date:  2020-03-20       Impact factor: 11.454

Review 8.  Metabolic alterations and hepatitis C: From bench to bedside.

Authors:  Ming-Ling Chang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 9.  Targeting immunometabolism to treat COVID-19.

Authors:  Shane M O'Carroll; Luke A J O'Neill
Journal:  Immunother Adv       Date:  2021-06-02

10.  The kidnapping of mitochondrial function associated with the SARS-CoV-2 infection.

Authors:  Elizabeth Soria-Castro; María Elena Soto; Verónica Guarner-Lans; Gustavo Rojas; Mario Perezpeña-Diazconti; Sergio A Críales-Vera; Linaloe Manzano Pech; Israel Pérez-Torres
Journal:  Histol Histopathol       Date:  2021-06-16       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.